Small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-04-20Clinical Trial Update: Safety and Efficacy of XmAb18087 ± Pembrolizumab in Advanced Merkel Cell Carcinoma or Extensive-stage Small Cell Lung Cancer [Phase 1, Phase 2]
Phase 1/2 trial evaluating XmAb18087 with or without pembrolizumab in advanced Merkel cell carcinoma and extensive-stage small cell lung can…
-
CLINICAL_TRIALS trial_result · 2023-04-11Clinical Trial Update: Molecular Profiling and Targeted Therapy for Advanced Non-Small Cell Lung Cancer, Small Cell Lung Cancer, and Thymic Malignancies [Phase 2]
A Phase 2 trial evaluating molecular profiling-guided targeted therapy across advanced non-small cell lung cancer, small cell lung cancer, a…
-
CLINICAL_TRIALS trial_result · 2023-03-30Clinical Trial Update: Combination Immunotherapy-Ipilimumab-Nivolumab-Dendritic Cell p53 Vac - Patients With Small Cell Lung Cancer (SCLC) [Phase 2]
Phase 2 trial evaluating a combination immunotherapy (ipilimumab-nivolumab) with dendritic cell p53 vaccine in relapsed small cell lung canc…
-
CLINICAL_TRIALS trial_result · 2023-03-29Clinical Trial Update: Maintenance Therapy for Small-cell Lung Cancer [Phase 2]
Phase 2 clinical trial update on maintenance therapy for small-cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2023-03-24Clinical Trial Update: STAD-1 Small Cell Lung Cancer Toxicity Adjusted Dosing Study [Phase 3]
Phase 3 trial update evaluating toxicity-adjusted dosing in small cell lung cancer.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-03-08Clinical Trial Update: Immunological Variables Associated to ICI Toxicity in Cancer Patients [Phase 2]
A Phase 2 clinical trial investigating immunological variables associated with immune checkpoint inhibitor toxicity in cancer patients.
-
CLINICAL_TRIALS trial_result · 2023-02-23Clinical Trial Update: S1 Plus Anlotinib in Treating Patients With Refractory or Relapsed Small-cell Lung Cancer [Phase 2]
Phase 2 trial update evaluating S1 plus Anlotinib in patients with refractory or relapsed small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2023-01-04Clinical Trial Update: Radiosurgery Plus NovoTTF-200A for Metastatic Small Cell Lung Cancer to the Brain [NA]
Clinical trial update for radiosurgery plus NovoTTF-200A in metastatic small cell lung cancer to the brain; the study is terminated with pos…
-
CLINICAL_TRIALS trial_result · 2022-11-29Clinical Trial Update: Surufatinib Combined With Irinotecan as a Second-line Treatment for Small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating surufatinib combined with irinotecan as a second-line treatment for small cell lung cancer; current status unknown.
-
CLINICAL_TRIALS trial_result · 2022-11-14Clinical Trial Update: Surufatinib Combined With Chemotherapy Plus Toripalimab or Not in the Treatment of Small Cell Lung Cancer [Phase 1, Phase 2]
Early-phase trial evaluating surufatinib with chemotherapy plus toripalimab (or without) in small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2022-09-16Clinical Trial Update: Pembrolizumab vs Topotecan in Patients With Small Cell Lung Cancer [Phase 2]
Phase 2 trial comparing pembrolizumab to topotecan in small cell lung cancer was terminated with results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-09-06Clinical Trial Update: Study of Surufatinib Combined With Sintilimab and SCRT in Advanced Solid Tumors [Phase 2]
Phase 2 trial evaluating surufatinib combined with sintilimab and SCRT in various unresectable advanced solid tumors, including biliary trac…
-
CLINICAL_TRIALS trial_result · 2022-07-19Clinical Trial Update: Apatinib for Extensive Stage Small Cell Lung Cancer After Second/Third Line Chemotherapy. [Phase 2]
Phase 2 clinical trial update evaluating apatinib for extensive-stage small cell lung cancer after second/third line chemotherapy has been c…
-
CLINICAL_TRIALS trial_result · 2022-06-09Clinical Trial Update: Trilaciclib (G1T28) in Patients With Previously Treated Extensive Stage SCLC Receiving Topotecan Chemotherapy [Phase 1, Phase 2]
Phase 1/2 trial update evaluating Trilaciclib (G1T28) to reduce chemotherapy-induced myelosuppression in patients with previously treated ex…
-
CLINICAL_TRIALS trial_result · 2022-05-31Clinical Trial Update: BI 2536 Second Line Monotherapy in SCLC [Phase 2]
A Phase 2 trial evaluating BI 2536 as second-line monotherapy for small cell carcinoma (small cell lung cancer) has been completed with resu…
-
CLINICAL_TRIALS trial_result · 2022-05-06Clinical Trial Update: Carboplatin, Etoposide, and Atezolizumab With or Without Trilaciclib (G1T28), a CDK4/6 Inhibitor, in Extensive-Stage SCLC [Phase 2]
Phase 2 trial evaluating carboplatin/etoposide/atezolizumab with or without trilaciclib (G1T28) in extensive-stage small cell lung cancer; r…
-
CLINICAL_TRIALS trial_result · 2022-05-04Clinical Trial Update: A Clinical Study to Evaluate the Efficacy and Safety of HLX07 Combination Therapy in Patients With Extensive Small Cell Lung Cancer [Phase 2]
Phase 2 clinical study evaluating HLX07 in combination therapy for extensive small cell lung cancer; current status unknown.
-
CLINICAL_TRIALS trial_result · 2022-05-02Clinical Trial Update: The Efficacy and Safety of Radiotherapy Plus Niraparib and Toripalimab in Patients With Recurrent Small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating radiotherapy combined with niraparib and toripalimab for recurrent small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2022-04-18Clinical Trial Update: Study of Carboplatin Plus Etoposide With or Without SHR-1316 in Participants With Untreated Extensive-Stage (ES) Small Cell Lung Cancer (SCLC) [Phase 3]
Phase 3 trial updates the evaluation of carboplatin and etoposide with or without SHR-1316 in untreated extensive-stage small cell lung canc…
-
CLINICAL_TRIALS trial_result · 2022-04-12Clinical Trial Update: Trial of Topotecan With VX-970 (M6620), an ATR Kinase Inhibitor, in Small Cell Cancers and Extrapulmonary Small Cell Cancers [Phase 1, Phase 2]
A Phase 1/2 trial update reports completed results for combining topotecan with the ATR inhibitor berzosertib (VX-970/M6620) in small cell c…
-
CLINICAL_TRIALS trial_result · 2022-04-12Clinical Trial Update: Amrubicin Study for Elderly Patients With Extensive-disease Small-cell Lung Cancer (ED-SCLC) [Phase 3]
Phase 3 trial update for amrubicin in elderly patients with extensive-disease small-cell lung cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2022-04-06Clinical Trial Update: Sequential Hypofractionated Radiotherapy Followed by Anti-PD-L1 Atezolizumab for SCLC [Phase 2]
Phase 2 clinical trial investigating sequential hypofractionated radiotherapy followed by the anti-PD-L1 agent atezolizumab for recurrent sm…
-
CLINICAL_TRIALS trial_result · 2022-04-06Clinical Trial Update: Irinotecan/Cisplatin With or Without Simvastatin in Chemo-naive Patients With Extensive Disease-small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating irinotecan/cisplatin with or without simvastatin in chemo-naive extensive-disease small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2022-03-28Clinical Trial Update: Utidelone in Third-line and Above Treatment of Small Cell Lung Cancer [Phase 2]
Phase 2 clinical trial update for Utidelone in third-line and above treatment of small cell lung cancer (extensive stage) is ongoing with un…
-
CLINICAL_TRIALS trial_result · 2022-02-18Clinical Trial Update: An Open Label, Multicenter Phase 2 Study of Durvalumab (MEDI4736) + Olaparib as Maintenance Therapy in Chinese [Phase 2]
An open-label multicenter Phase 2 study evaluating maintenance Durvalumab (MEDI4736) plus Olaparib in Chinese patients with lung cancer and …